Breath and DNA tests could personalize prostate cancer radiation
NCT ID NCT04081428
First seen Feb 20, 2026 · Last updated May 26, 2026 · Updated 8 times
Summary
This study looks at whether breath, DNA, and imaging can help doctors predict how prostate cancer and healthy tissues react to a precise type of radiation called SBRT. Sixty men with low- or intermediate-risk prostate cancer will provide breath and blood samples before and after each of five radiation sessions. The goal is to find ways to personalize treatment to improve cure rates and reduce side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Edinburgh Cancer Centre, Western General Hospital
Edinburgh, Mid Lothian, EH4 2XU, United Kingdom
Conditions
Explore the condition pages connected to this study.